High payload nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6 for synergistic chemo-photodynamic combination therapy
Source abstract
Abstract
Abstract Combined chemo-photodynamic therapy strategy is regarded as a potential strategy for advanced cancer treatments. Herein, novel high payload 7-ethyl-10-hydroxycamptothecin (SN38)/chlorin e6 (Ce6) NPs based on the collaborative assembly of the pre-obtained SN38–Ce6 complex and biocompatible amphiphilic block polymer DSPE-PEG2000 were successfully constructed. The self-assembly mechanism of the NPs was corporately disclosed as static quenching resulted from complex formation between DSPE-PEG2000 and the pre-acquired SN38–Ce6 complex via fluorescence quenching experiment. The high payload SN38/Ce6 NPs exhibited uniform rod-like morphology with a hydrodynamic radius of about 200 nm, a zeta potential of around −25 mV, and excellent storage stability. The high payload NPs showed efficient singlet oxygen generation capacity both in tube and in murine mammary carcinoma (4T1) cells under laser irradiation. Moreover, the in vitro cytotoxicity and in vivo antitumor efficacy of the NPs (with laser) against 4T1 cell lines model were proved to be statistically significant compared to CPT-11 injection and single-drug NPs due to synergistic chemo-photodynamic therapy and high cellular uptake efficiency. Meanwhile, the systemic toxicity of the NPs was basically absent. Conclusively, the high payload dual-functional nanoparticles could be served as a promising strategy for cancer treatment in clinic.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. A light-triggered self-reinforced nanoagent for targeted chemo-photodynamic therapy of breast cancer bone metastases via ER stress and mitochondria mediated apoptotic pathways10.1016/j.jconrel.2019.12.043 ↗
2. NIR-Light-Activated combination therapy with a precise ratio of photosensitizer and prodrug using a host–guest strategy10.1002/anie.201900886 ↗
3. NIR-responsive ROS generating core and ROS-triggered 5′-Deoxy-5-fluorocytidine releasing shell structured water-swelling microgel for locoregional combination cancer therapy10.1016/j.jconrel.2019.05.016 ↗
4. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy10.1016/j.ejmech.2016.12.056 ↗
5. Synergistic chemo-photodynamic therapy by “big & small combo nanoparticles” sequential release system10.1016/j.nano.2017.09.002 ↗
6. Light/pH-Triggered biomimetic red blood cell membranes camouflaged small molecular drug assemblies for imaging-guided combinational chemo-photothermal therapy10.1021/acsami.9b00897 ↗
7. A nano-complex system to overcome antagonistic photo-chemo combination cancer therapy10.1016/j.jconrel.2018.12.043 ↗
8. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy10.1016/j.biomaterials.2018.09.033 ↗
9. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy10.1016/j.jconrel.2018.04.030 ↗
10. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy10.1016/j.ejmech.2018.03.077 ↗
11. Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance10.1021/acsami.6b03881 ↗
12. An intelligent nanoplatform for imaging-guided photodynamic/photothermal/chemo-therapy based on upconversion nanoparticles and CuS integrated black phosphorus10.1016/j.cej.2019.122822 ↗
13. Carrier-free core–shell nanodrugs for synergistic two-photon photodynamic therapy of cervical cancer10.1016/j.jcis.2018.09.095 ↗
14. An intelligent nanoplatform for simultaneously controlled chemo-, photothermal, and photodynamic therapies mediated by a single NIR light10.1016/j.cej.2019.01.095 ↗
15. Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance10.1016/j.drup.2017.05.002 ↗
16. Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer10.1038/nmat1524 ↗
17. Cargo-free nanomedicine with pH sensitivity for codelivery of DOX conjugated prodrug with SN38 to synergistically eradicate breast cancer stem cells10.1021/acs.molpharmaceut.8b00367 ↗
18. Carrier-free functionalized multidrug nanorods for synergistic cancer therapy10.1016/j.biomaterials.2013.07.080 ↗
19. A small molecule nanodrug by self-assembly of dual anticancer drugs and photosensitizer for synergistic near-infrared cancer theranostics10.1021/acsami.7b14755 ↗
20. Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo10.1039/C7NR03129G ↗
21. Carrier-free, chemophotodynamic dual nanodrugs via self-assembly for synergistic antitumor therapy10.1021/acsami.6b02416 ↗
22. Novel carrier-free nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6: self-assembly mechanism investigation and in vitro/in vivo evaluation10.1016/j.colsurfb.2019.110722 ↗
23. Shape of nanoparticles as a design parameter to improve docetaxel antitumor efficacy10.1021/acs.bioconjchem.8b00059 ↗
24. Hydroxycamptothecin nanorods prepared by fluorescently labeled oligoethylene glycols (OEG) codendrimer: antitumor efficacy in vitro and in vivo10.1021/acs.bioconjchem.6b00536 ↗
25. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: in vitro/in vivo evaluation and binding properties investigation10.1016/j.ijbiomac.2020.03.060 ↗
26. Comparative study on the interaction of oxyresveratrol and piceatannol with trypsin and lysozyme: binding ability, activity and stability10.1039/C9FO01888C ↗
27. Investigation of binary and ternary systems of human serum albumin with oxyresveratrol/piceatannol and/or mitoxantrone by multipectroscopy, molecular docking and cytotoxicity evaluation10.1016/j.molliq.2020.113364 ↗
28. Spectroscopic and cytotoxicity studies on the combined interaction of (−)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin10.1016/j.saa.2019.117213 ↗
29. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy10.1016/j.actbio.2020.03.027 ↗
30. A phototheranostic nanoparticle for cancer therapy fabricated by BODIPY and graphene to realize photo-chemo synergistic therapy and fluorescence/photothermal imaging10.1016/j.dyepig.2020.108262 ↗
31. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides10.2147/IJN.S122859 ↗
32. A computer-aided chem-photodynamic drugs self-delivery system for synergistically enhanced cancer therapy
33. Design and synthesis of a fluorescent amino poly(glycidyl methacrylate) for efficient gene delivery10.1039/C8TB02968G ↗
34. High Affinity of Chlorin e6 to Immunoglobulin G for Intraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy10.1021/acsnano.9b03466 ↗
35. Assemblies of indocyanine green and chemotherapeutic drug to cure established tumors by synergistic chemo-photo therapy10.1016/j.jconrel.2020.05.018 ↗
36. NanoSOSG: a nanostructured fluorescent probe for the detection of intracellular singlet oxygen10.1002/anie.201609050 ↗
37. Two-photon excited organic nanoparticles for chemo-photodynamic therapy10.1016/j.dyepig.2019.04.038 ↗
38. Self-assembly of photosensitive and chemotherapeutic drugs for combined photodynamic-chemo cancer therapy with real-time tracing property10.1016/j.colsurfa.2019.04.060 ↗
39. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo
40. Co-delivery of pirarubicin and paclitaxel by human serum albumin nanoparticles to enhance antitumor effect and reduce systemic toxicity in breast cancers10.1021/acs.molpharmaceut.5b00536 ↗
41. Endocytic mechanisms of graphene oxide nanosheets in osteoblasts, hepatocytes and macrophages10.1021/am5031598 ↗
42. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells10.1016/j.jconrel.2008.07.017 ↗
43. Photo-triggered self-destructive ROS-responsive nanoparticles of high paclitaxel/chlorin e6 co-loading capacity for synergetic chemo-photodynamic therapy10.1016/j.jconrel.2020.04.027 ↗
44. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer10.1016/j.biomaterials.2014.04.034 ↗
45. Near Infrared (NIR) absorbing dyes as promising photosensitizer for photo dynamic therapy10.1016/j.ccr.2020.213233 ↗
46. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy10.1016/j.actbio.2019.05.008 ↗
47. pH-responsive metallo-supramolecular nanogel for synergistic chemo-photodynamic therapy10.1016/j.actbio.2015.07.024 ↗
48. NIR-Light-Activated combination therapy with a precise ratio of photosensitizer and prodrug using a host–guest strategy10.1002/ange.201900886 ↗
49. Multistage tumor microenvironment-responsive theranostic nanopeanuts: toward multimode imaging guided chemo-photodynamic therapy10.1016/j.cej.2019.123893 ↗